TELA Bio annual debt-to-equity ratio
2019
2020
2021
2022
2023
2024
2025
TELA Bio Debt-to-Equity Ratio Growth & History (TELA)
TELA Bio's debt-to-equity ratio was 9.13 for fiscal 2025.
View full TELA Bio company overviewTELA Bio annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 9.13 | 7.62 | +503.58% |
| 2024 | 2024-12-31 | 1.51 | −0.75 | −33.20% |
| 2023 | 2023-12-31 | 2.26 | −0.64 | −21.90% |
| 2022 | 2022-12-31 | 2.90 | 1.33 | +85.09% |
| 2021 | 2021-12-31 | 1.57 | 0.94 | +149.19% |
| 2020 | 2020-12-31 | 0.63 | −0.35 | −35.63% |
| 2019 | 2019-12-31 | 0.98 | — | — |
TELA Bio quarterly debt-to-equity ratio
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 9.13 | 7.62 | +503.58% |
| Q3 2025 | 2025-09-30 | 26.98 | — | — |
| Q2 2025 | 2025-06-30 | 4.56 | −9.86 | −68.36% |
| Q1 2025 | 2025-03-31 | 2.31 | −0.56 | −19.53% |
| Q4 2024 | 2024-12-31 | 1.51 | −0.75 | −33.20% |
| Q2 2024 | 2024-06-30 | 14.42 | 13.38 | +1284.17% |
| Q1 2024 | 2024-03-31 | 2.87 | −10.37 | −78.35% |
| Q4 2023 | 2023-12-31 | 2.26 | −0.64 | −21.90% |
| Q3 2023 | 2023-09-30 | 1.37 | −0.41 | −23.01% |
| Q2 2023 | 2023-06-30 | 1.04 | — | — |
| Q1 2023 | 2023-03-31 | 13.24 | 9.91 | +298.12% |
| Q4 2022 | 2022-12-31 | 2.90 | 1.33 | +85.09% |
| Q3 2022 | 2022-09-30 | 1.78 | 0.65 | +57.28% |
| Q1 2022 | 2022-03-31 | 3.33 | 2.58 | +347.48% |
| Q4 2021 | 2021-12-31 | 1.57 | 0.94 | +149.19% |
| Q3 2021 | 2021-09-30 | 1.13 | 0.58 | +107.41% |
| Q2 2021 | 2021-06-30 | 0.89 | 0.41 | +85.02% |
| Q1 2021 | 2021-03-31 | 0.74 | −0.51 | −40.74% |
| Q4 2020 | 2020-12-31 | 0.63 | −0.35 | −35.63% |
| Q3 2020 | 2020-09-30 | 0.54 | — | — |
| Q2 2020 | 2020-06-30 | 0.48 | — | — |
| Q1 2020 | 2020-03-31 | 1.25 | — | — |
| Q4 2019 | 2019-12-31 | 0.98 | — | — |
TELA Bio debt-to-equity ratio trends
Over the last five fiscal years, TELA Bio's debt-to-equity ratio increased from 0.63 to 9.13, a change of 8.50. The latest reported quarter, Q4 2025, shows 9.13.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TELA Bio source filings ↗